Literature DB >> 15646406

Slime factor positivity in coagulase negative staphylococci isolated from nasal samples of haemodialysis patients.

U Altoparlak1, A Kadanali, S Celebi.   

Abstract

Polysaccharide slime seems to be the most important factor by which coagulase negative staphylococci (CNS) strains adheres and colonises catheters. The aim of this study was to determine the prevalence of slime-producing CNS strains isolated from nasal samples of patients on haemodialysis and of healthy persons as a control. Nasal cultures were performed for 131 haemodialysis patients and 56 healthy persons. CNS strains were isolated from 86 of 131 patients (72.9%), and 46 of 56 healthy persons (82.1%). Twenty-four (27.9%) of the 86 CNS strains tested in the patient group and four (8.7%) of the 46 CNS strains in the control group were slime factor positive. There was a significant difference (p<0.01) in slime production between CNS strains isolated from haemodialysis patients and from control group. The detection of slime-producing coagulase-negative staphylococcus carriage in haemodialysis patients may prevent dialysis catheter-related coagulase-negative staphylococcal infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15646406     DOI: 10.1111/j.1742-1241.2004.00211.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  3 in total

1.  Risk factors for infection with coagulase-negative staphylococci in newborns from the neonatal unit of a brazilian university hospital.

Authors:  Adilson de Oliveira; Patrícia Sanches; João C Lyra; Maria R Bentlin; Ligia M S S Rugolo; Maria de Lourdes Ribeiro de Souza da Cunha
Journal:  Clin Med Insights Pediatr       Date:  2011-12-15

2.  Antimicrobial activity of some sulfonamide derivatives on clinical isolates of Staphylococus aureus.

Authors:  Yeliz Genç; Reşit Ozkanca; Yunus Bekdemir
Journal:  Ann Clin Microbiol Antimicrob       Date:  2008-08-20       Impact factor: 3.944

3.  Novel essential amino acid-sulfanilamide hybrid as safe anti-ulcerogenic agent with anti-helicobacter pylori activity.

Authors:  Amani S Awaad; Ahmed M Alafeefy; Fatmah A S Alasmary; Reham M El-Meligy; M E Zain; Saleh I Alqasoumi
Journal:  Saudi Pharm J       Date:  2017-02-27       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.